1. Maternal Food Restriction during Pregnancy and Lactation Adversely Affect Hepatic Growth and Lipid Metabolism in Three-Week-Old Rat Offspring
   Sangmi Lee et al, 2016, IJMS CrossRef
2. Gomisin J Inhibits Oleic Acid-Induced Hepatic Lipogenesis by Activation of the AMPK-Dependent Pathway and Inhibition of the Hepatokine Fetuin-A in HepG2 Cells
   Myungsuk Kim et al, 2015, J. Agric. Food Chem. CrossRef
3. Kaurenoic acid, a Diterpene Derived from , Alleviates Lipogenesis in HepG2 Cells.
   Yu Gon Kim et al, 2015, J Korean Med CrossRef
4. null
   Shigeatsu Hashimoto, 2016 CrossRef
5. Xyloketal B Attenuates Fatty Acid-Induced Lipid Accumulation via the SREBP-1c Pathway in NAFLD Models
   Youying Zhang et al, 2017, Marine Drugs CrossRef
6. Osthol attenuates hepatic steatosisviadecreased triglyceride synthesis not by insulin resistance
   Ho Hyun Nam, 2014, WJG CrossRef
7. Hepcidin/ferroportin expression levels involve efficacy of pegylated-interferon plus ribavirin in hepatitis C virus-infected liver
   Motoyuki Kohjima et al, 2015, WJG CrossRef
8. Systematic review: Preventive and therapeutic applications of metformin in liver disease
   Aparna Bhat, 2015, WJH CrossRef
9. Bee Venom Suppresses the Differentiation of Preadipocytes and High Fat Diet-Induced Obesity by Inhibiting Adipogenesis
   Se-Yun Cheon et al, 2017, Toxins CrossRef
10. miR-146b Inhibits Glucose Consumption by Targeting IRS1 Gene in Porcine Primary Adipocytes
    Yan-Ling Zhu et al, 2018, IJMS CrossRef
11. Polyacetylene From Dendropanax morbifera Alleviates Diet-Induced Obesity and Hepatic Steatosis by Activating AMPK Signaling Pathway
    Myung-Ji Kang et al, 2018, Front. Pharmacol. CrossRef
12. Flavonones from Penthorum chinense Ameliorate Hepatic Steatosis by Activating the SIRT1/AMPK Pathway in HepG2 Cells
    Wei-Wei Guo et al, 2018, IJMS CrossRef
13. Regulation and Metabolic Significance of De Novo Lipogenesis in Adipose Tissues
    Ziyi Song et al, 2018, Nutrients CrossRef
14. Nifedipine Modulates Renal Lipogenesis via the AMPK-SREBP Transcriptional Pathway
    Yen-Chung Lin et al, 2019, IJMS CrossRef
15. Lactobacillus plantarum NA136 improves the non-alcoholic fatty liver disease by modulating the AMPK/Nrf2 pathway
    Zijian Zhao et al, 2019, Appl Microbiol Biotechnol CrossRef
16. Rice Hull Extract (RHE) Suppresses Adiposity in High-Fat Diet-Induced Obese Mice and Inhibits Differentiation of 3T3-L1 Preadipocytes
    Ga-Hee Kim et al, 2019, Nutrients CrossRef
17. Acetyl-CoA carboxylase inhibition regulates microtubule dynamics and intracellular transport in cystic fibrosis epithelial cells
    Sharon M. Rymut et al, 2019, American Journal of Physiology-Lung Cellular and Molecular Physiology CrossRef
18. Benzyl Isothiocyanate and Phenethyl Isothiocyanate Inhibit Adipogenesis and Hepatosteatosis in Mice with Obesity Induced by a High-Fat Diet
    Wei-Ting Chuang et al, 2019, J. Agric. Food Chem. CrossRef
19. Allomyrina dichotoma Larva Extract Ameliorates the Hepatic Insulin Resistance of High-Fat Diet-Induced Diabetic Mice.
    Hee-Sook Jun, 0 CrossRef
20. Adenosine Monophosphate-Activated Protein Kinase Signaling Regulates Lipid Metabolism in Response to Salinity Stress in the Red-Eared Slider Turtle Trachemys scripta elegans
    Meiling Hong et al, 2019, Front. Physiol. CrossRef
21. Antioxidant Versus Pro-Apoptotic Effects of Mushroom-Enriched Diets on Mitochondria in Liver Disease
    Adriana Fontes et al, 2019, IJMS CrossRef
22. Lyophilized Maqui (Aristotelia chilensis) Berry Induces Browning in the Subcutaneous White Adipose Tissue and Ameliorates the Insulin Resistance in High Fat Diet-Induced Obese Mice
    Viviana Sandoval et al, 2019, Antioxidants CrossRef
23. Dietary Bile Acids Enhance Growth, and Alleviate Hepatic Fibrosis Induced by a High Starch Diet via AKT/FOXO1 and cAMP/AMPK/SREBP1 Pathway in Micropterus salmoides
    Huanhuan Yu et al, 2019, Front. Physiol. CrossRef
24. Fatty Acids and Effects on In Vitro and In Vivo Models of Liver Steatosis
    Laura Vergani, 2019, CMC CrossRef
25. Lactobacillus plantarum FRT10 alleviated high-fat diet–induced obesity in mice through regulating the PPARα signal pathway and gut microbiota
    Hongying Cai et al, 2020, Appl Microbiol Biotechnol CrossRef
26. Ganoderic acid A attenuates high-fat-diet-induced liver injury in rats by regulating the lipid oxidation and liver inflammation
    Fuli Liu et al, 2020, Arch. Pharm. Res. CrossRef
27. Non-alcoholic Fatty Liver Disease and Alcohol-Related Liver Disease: Two Intertwined Entities
    Francisco Idalsoaga et al, 2020, Front. Med. CrossRef
28. Transcriptional Regulation in Non-Alcoholic Fatty Liver Disease
    Sandra Steensels et al, 2020, Metabolites CrossRef
29. Pathophysiology of NAFLD and NASH in Experimental Models: The Role of Food Intake Regulating Peptides
    L. Kořínková et al, 2020, Front. Endocrinol. CrossRef
30. Critical Role for AMPK in Metabolic Disease-Induced Chronic Kidney Disease
    Florian Juszczak et al, 2020, IJMS CrossRef
31. In Vitro and In Vivo Models of Non-Alcoholic Fatty Liver Disease: A Critical Appraisal
    Pierre-Antoine Soret et al, 2020, JCM CrossRef
32. Experimental models of metabolic and alcoholic fatty liver disease
    Delfin Gerard Buyco et al, 2021, WJG CrossRef
33. Protective Effects of Iridoid Glycoside from Corni Fructus on Type 2 Diabetes with Nonalcoholic Fatty Liver in Mice
    Dou Niu et al, 2021, BioMed Research International CrossRef
34. Investigating the Opposing Effect of Two Different Green Tea Supplements on Oxidative Stress, Mitochondrial Function and Cell Viability in HepG2 Cells
    Aparna Shil et al, 2021, Journal of Dietary Supplements CrossRef
35. Non-Alcoholic Fatty Liver Disease Is an Independent Risk Factor for LDL Cholesterol Target Level
    Jun-Hyuk Lee et al, 2021, IJERPH CrossRef
36. Non-Alcoholic Fatty Liver Disease and Cardiovascular Comorbidities: Pathophysiological Links, Diagnosis, and Therapeutic Management
    Alexandra Jichitu et al, 2021, Diagnostics CrossRef
37. The effects of quercetin on the expression of SREBP-1c mRNA in high-fat diet-induced NAFLD in mice
    Jamal Nasser Saleh Al-maamari et al, 2021 CrossRef
38. Abnormal Metabolism in the Progression of Nonalcoholic Fatty Liver Disease to Hepatocellular Carcinoma: Mechanistic Insights to Chemoprevention
    Danny Orabi et al, 2021, Cancers CrossRef
39. A Narrative Review on the Role of AMPK on De Novo Lipogenesis in Non-Alcoholic Fatty Liver Disease: Evidence from Human Studies.
    Christian von Loeffelholz et al, 2021, Cells CrossRef
40. Similarities and Differences: A Comparative Review of the Molecular Mechanisms and Effectors of NAFLD and AFLD
    Pengyi Zhang et al, 2021, Front. Physiol. CrossRef
41. Phytotherapy as Multi-Hit Therapy to Confront the Multiple Pathophysiology in Non-Alcoholic Fatty Liver Disease: A Systematic Review of Experimental Interventions
    Ayokanmi Ore et al, 2021, Medicina CrossRef
42. Metformin Alleviates Steatohepatitis in Diet-Induced Obese Mice in a SIRT1-Dependent Way
    Wan-rong Guo et al, 2021, Front. Pharmacol. CrossRef
43. AGL9: A Novel Hepatoprotective Peptide from the Larvae of Edible Insects Alleviates Obesity-Induced Hepatic Inflammation by Regulating AMPK/Nrf2 Signaling
    Meiqi Fan et al, 2021, Foods CrossRef
44. Mixed steatohepatitis: more questions than answers (Part 1)
    K. L. Raikhelson et al, 2020, Terapevticheskii arkhiv CrossRef
45. Inhibition of Atherosclerosis and Liver Steatosis by Agmatine in Western Diet-Fed apoE-Knockout Mice Is Associated with Decrease in Hepatic De Novo Lipogenesis and Reduction in Plasma Triglyceride/High-Density Lipoprotein Cholesterol Ratio
    Anna Wiśniewska et al, 2021, IJMS CrossRef
46. Physiological Changes and Pathological Pain Associated with Sedentary Lifestyle-Induced Body Systems Fat Accumulation and Their Modulation by Physical Exercise
    Enrique Verdú et al, 2021, IJERPH CrossRef
47. Cell-Type Resolved Insights into the Cis-Regulatory Genome of NAFLD
    Trine V. Dam et al, 2022, Cells CrossRef
48. Extract of Ranunculus sceleratus Reduced Adipogenesis by Inhibiting AMPK Pathway in 3T3-L1 Preadipocytes
    Yae-Ji Kim et al, 2022, JKOMOR CrossRef
49. Effects of a Phosphodiesterase inhibitor on the Browning of Adipose Tissue in Mice
    Da Hea Seo et al, 2022, Biomedicines CrossRef
50. Salvianolic acid B ameliorates non-alcoholic fatty liver disease by inhibiting hepatic lipid accumulation and NLRP3 inflammasome in ob/ob mice
    Ling-Cui Meng et al, 2022, International Immunopharmacology CrossRef
51. Reversal of High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease by Metformin Combined with PGG, an Inducer of Glycine N-Methyltransferase
    Ming-Hui Yang et al, 2022, IJMS CrossRef
52. Xenobiotics Delivered by Electronic Nicotine Delivery Systems: Potential Cellular and Molecular Mechanisms on the Pathogenesis of Chronic Kidney Disease
    Pablo Scharf et al, 2022, IJMS CrossRef
53. Capparis spinosa improves non-alcoholic steatohepatitis through down-regulating SREBP-1c and a PPARα-independent pathway in high-fat diet-fed rats
    Rasoul Akbari et al, 2022, BMC Res Notes CrossRef
54. CircRNA screening and ceRNA network construction for milk fat metabolism in dairy cows
    Xiaofang Feng et al, 2022, Front. Vet. Sci. CrossRef
55. Genetics, epigenetics and transgenerational transmission of obesity in children
    Nadia Panera et al, 2022, Front. Endocrinol. CrossRef
56. Combined transcriptomics and in-silico approach uncovers the role of prognostic biomarkers in hepatocellular carcinoma
    Rubi Solanki et al, 2023, Human Gene CrossRef